Literature DB >> 4070923

Rheumatoid factors in rheumatoid arthritis and vasculitis.

M L Westedt, P Herbrink, J L Molenaar, E de Vries, P Verlaan, T Stijnen, A Cats, J Lindeman.   

Abstract

To study the occurrence of rheumatoid factors (RF) in relation to the activity of rheumatoid arthritis and the occurrence of vasculitis, RF of IgM, IgA, and IgG classes were measured in sera from 35 patients with definite or classic rheumatoid arthritis (RA) using ELISA. For 26 patients, the RF levels were studied longitudinally and compared with changes in the articular index. Although IgM RF was occasionally found in patients without RA, IgA and/or IgG RF were almost exclusively associated with RA. The titers of IgM, IgA, and IgG RF were significantly higher in sera from patients with clinically diagnosed rheumatoid vasculitis than in sera from patients without vasculitis. No significant correlation between changes in the articular index and changes in titer of any class-specific RF could be found for the group of RA patients as a whole. However, in individual patients, increases or decreases in IgM and IgG RF titer were significantly correlated with an increase or decrease in the articular index.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4070923     DOI: 10.1007/BF00541338

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  17 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  An immunofluorescence procedure for the detection of intracellular immunoglobulins.

Authors:  W Hijmans; H R Schuit; F Klein
Journal:  Clin Exp Immunol       Date:  1969-04       Impact factor: 4.330

3.  IgM rheumatoid factor and low molecular weight IgM. An association with vasculitis.

Authors:  A N Theofilopoulos; G Burtonboy; J J LoSpalluto; M Ziff
Journal:  Arthritis Rheum       Date:  1974 May-Jun

4.  False positive results in class-specific rheumatoid factor (RF) assays due to interaction between RF and Fc fragments of anti-immunoglobulin indicator reagents.

Authors:  A Tarkowski; L M Bjursten; L A Nilsson; H Nygren
Journal:  J Immunol Methods       Date:  1983-03-11       Impact factor: 2.303

5.  Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis. Partial characterization and relationship to lowered complement levels.

Authors:  R J Winchester; V Agnello; H G Kunkel
Journal:  Clin Exp Immunol       Date:  1970-05       Impact factor: 4.330

6.  Radioimmunoassay of IgG and IgM rheumatoid factors reacting with human IgG.

Authors:  D A Carson; S Lawrance; M A Catalano; J H Vaughan; G Abraham
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

7.  IgG-, IgM- and IgA-rheumatoid factors in healthy adults and rheumatoid patients determined by an indirect immunofluorescence method.

Authors:  H E Kallerup; E M Egeskjold; H Graudal
Journal:  Scand J Rheumatol       Date:  1979       Impact factor: 3.641

8.  Immunoglobulin class of rheumatoid factors detected by enzyme-linked immunosorbent assay.

Authors:  T Nishimaki; S Watanabe; H Yoshida; R Kasukawa
Journal:  Clin Rheumatol       Date:  1983-06       Impact factor: 2.980

9.  IgG rheumatoid factor. Relationship to seropositive rheumatoid arthritis and absence in seronegative disorders.

Authors:  R M Pope; S J McDuffy
Journal:  Arthritis Rheum       Date:  1979-09

10.  Prospective study of early rheumatoid arthritis. I. Prognostic value of IgA rheumatoid factor.

Authors:  I Teitsson; R H Withrington; M H Seifert; H Valdimarsson
Journal:  Ann Rheum Dis       Date:  1984-10       Impact factor: 19.103

View more
  20 in total

1.  Significance of rheumatoid factors in an eight-year longitudinal study on arthritis.

Authors:  T Tuomi; K Aho; T Palosuo; K Kaarela; R von Essen; H Isomäki; M Leirisalo-Repo; S Sarna
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

2.  Effects of rheumatoid factor isotypes on disease activity and severity in patients with rheumatoid arthritis: a comparative study.

Authors:  Aşkin Ateş; Gülay Kinikli; Murat Turgay; Gülay Akay; Güner Tokgöz
Journal:  Clin Rheumatol       Date:  2006-06-28       Impact factor: 2.980

3.  No interference of rheumatoid factor(s) with toxoplasmosis IgM determination in infancy.

Authors:  O Djurković-Djaković; N Milosević-Jovcić; S Zerjav; D Sibalić
Journal:  Eur J Pediatr       Date:  1992-01       Impact factor: 3.183

4.  The association of choroidal thickness with rheumatoid factor and anti-cyclic citrullinated peptide in rheumatoid arthritis.

Authors:  Arif Ülkü Yener; Kubilay Şahin
Journal:  Int Ophthalmol       Date:  2020-01-11       Impact factor: 2.031

5.  Determination of IgA- and IgM-rheumatoid factors in patients with rheumatoid arthritis with and without nephropathy.

Authors:  M Nakano; M Ueno; S Nishi; S Suzuki; H Hasegawa; T Watanabe; T Kuroda; S Ito; M Arakawa
Journal:  Ann Rheum Dis       Date:  1996-08       Impact factor: 19.103

6.  Standardisation of serological tests for rheumatoid factor measurement.

Authors:  F Klein; M B Janssens
Journal:  Ann Rheum Dis       Date:  1987-09       Impact factor: 19.103

7.  Serodiagnosis of respiratory syncytial virus (RSV) infection in children as measured by detection of RSV-specific immunoglobulins G, M, and A with enzyme-linked immunosorbent assay.

Authors:  M J Meddens; P Herbrink; J Lindeman; W C van Dijk
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

8.  Anti-cyclic citrullinated peptide, rheumatoid factor, and ocular symptoms typical of rheumatoid arthritis.

Authors:  Sujit Itty; Jose S Pulido; Sophie J Bakri; Keith H Baratz; Eric L Matteson; David O Hodge
Journal:  Trans Am Ophthalmol Soc       Date:  2008

9.  Bone mineral density in patients with recently diagnosed, active rheumatoid arthritis.

Authors:  M Güler-Yüksel; J Bijsterbosch; Y P M Goekoop-Ruiterman; J K de Vries-Bouwstra; H K Ronday; A J Peeters; J M de Jonge-Bok; F C Breedveld; B A C Dijkmans; C F Allaart; W F Lems
Journal:  Ann Rheum Dis       Date:  2007-04-24       Impact factor: 19.103

10.  Complement-activating properties of immune complexes are suppressed by IgM rheumatoid factor and enhanced by IgG rheumatoid factor.

Authors:  M Shingu; I Ezaki; M Nobunaga
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.